“It’s American Idol for medtech–no singing,” Paul Grand, managing director at RCT Ventures, said when describing the firm’s MedTech Idol competition. Early-stage medical device companies can apply to compete for direct feedback from venture capitalists, as well as a scholarship to the IN3 Medical Device 360 and a profile in Elsevier‘s magazine. Oh, and though […]
Venture capital for early-stage medical device companies is drying up. At Advamed 2013, I was able to sit down and talk to Paul Grand, managing director at Research Corporation Technologies Ventures, a life sciences firm focused primarily on medical devices. When I asked him what the three main mistakes startups make when pitching him, he […]
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.